UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.041

Sortiert nach

Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

Journal of clinical oncology, 2012-09, Vol.30 (26), p.3264-3270

2012

Link zum Volltext

Verfügbarkeit prüfen

Key role for myeloid cells: Phase II results of anti‐GD2 antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

International journal of cancer, 2014-11, Vol.135 (9), p.2199-2205

2014

Link zum Volltext

Verfügbarkeit prüfen

Improving outcomes in emergency general surgery: Construct of a collaborative quality initiative

The journal of trauma and acute care surgery, 2024-05, Vol.96 (5), p.715

2024

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system relapse of rhabdomyosarcoma

Pediatric blood & cancer, 2018-01, Vol.65 (1), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Oncoimmunology, 2018-01, Vol.7 (8), p.e1461305-e1461305

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors

PloS one, 2017-06, Vol.12 (6), p.e0178593-e0178593

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma

Cancers, 2021-12, Vol.13 (24), p.6265

2021

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma

Journal of clinical oncology, 2006-11, Vol.24 (33), p.5271-5276

2006

Link zum Volltext

Verfügbarkeit prüfen

(S047) CNS Relapse of Rhabdomyosarcoma

International journal of radiation oncology, biology, physics, 2017-06, Vol.98 (2), p.E14-E14

2017

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma

Journal of clinical oncology, 2009-03, Vol.27 (7), p.1041-1046

2009

Link zum Volltext

Verfügbarkeit prüfen

Ifosfamide, carboplatin, and etoposide for neuroblastoma

Cancer, 2013-02, Vol.119 (3), p.665-671

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of the Anti-GD2 Monoclonal Antibody 3F8 and Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma

Journal of clinical oncology, 2001-11, Vol.19 (22), p.4189-4194

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

Journal of hematology and oncology, 2022-11, Vol.15 (1), p.1-12, Article 165

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Targeted Radioimmunotherapy for Leptomeningeal Cancers Using Intra-Ommaya 131-I-3F8

Journal of clinical oncology, 2007-12, Vol.25 (34), p.5465-5470

2007

Link zum Volltext

Verfügbarkeit prüfen

Reduction From Seven to Five Cycles of Intensive Induction Chemotherapy in Children With High-Risk Neuroblastoma

Journal of clinical oncology, 2004-12, Vol.22 (24), p.4888-4892

2004

Link zum Volltext

Verfügbarkeit prüfen

Rare Primary CNS Tumors Encountered in Pediatrics

Journal of child neurology, 2016-01, Vol.31 (12), p.1394-1398

Kramer, Kim

2016

Link zum Volltext

Verfügbarkeit prüfen

Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study

The Journal of nuclear medicine (1978), 2016-02, Vol.57 (2), p.231-237

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-term complications in survivors of advanced stage neuroblastoma

Pediatric Blood & Cancer, 2005-09, Vol.45 (3), p.324-332

2005

Link zum Volltext

Verfügbarkeit prüfen

The impact of gross total resection on local control and survival in high-risk neuroblastoma

Journal of pediatric surgery, 2004-03, Vol.39 (3), p.412-417

2004

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections

Journal of pediatric surgery, 2010-10, Vol.45 (10), p.1961-1966

2010

Link zum Volltext

Verfügbarkeit prüfen

Rare Primary Central Nervous System Tumors Encountered in Pediatrics

Journal of child neurology, 2016-10, Vol.31 (12), p.1394-1398

Kramer, Kim

2016

Link zum Volltext

Verfügbarkeit prüfen

Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of Patients

Journal of clinical oncology, 2001-07, Vol.19 (14), p.3397-3405

2001

Link zum Volltext

Verfügbarkeit prüfen

DIPG-16. DELAYED RT IN SELECT PATIENTS WITH DIPG

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i51-i52

2018

Link zum Volltext

Verfügbarkeit prüfen

Medulloblastoma

Journal of child neurology, 2016-10, Vol.31 (12), p.1341-1353

2016

Link zum Volltext

Verfügbarkeit prüfen

Hyperfractionated Low-Dose Radiotherapy for High-Risk Neuroblastoma After Intensive Chemotherapy and Surgery

Journal of clinical oncology, 2001-06, Vol.19 (11), p.2821-2828

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.041

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(923)
Mit Volltextzugriff
(941)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

Key role for myeloid cells: Phase II results of anti‐GD2 antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

Improving outcomes in emergency general surgery: Construct of a collaborative quality initiative

Central nervous system relapse of rhabdomyosarcoma

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors

Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma

Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma

(S047) CNS Relapse of Rhabdomyosarcoma

Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma

Ifosfamide, carboplatin, and etoposide for neuroblastoma

Phase II Trial of the Anti-GD2 Monoclonal Antibody 3F8 and Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

Phase I Study of Targeted Radioimmunotherapy for Leptomeningeal Cancers Using Intra-Ommaya 131-I-3F8

Reduction From Seven to Five Cycles of Intensive Induction Chemotherapy in Children With High-Risk Neuroblastoma

Rare Primary CNS Tumors Encountered in Pediatrics

Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study

Long-term complications in survivors of advanced stage neuroblastoma

The impact of gross total resection on local control and survival in high-risk neuroblastoma

Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections

Rare Primary Central Nervous System Tumors Encountered in Pediatrics

Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of Patients

DIPG-16. DELAYED RT IN SELECT PATIENTS WITH DIPG

Medulloblastoma

Hyperfractionated Low-Dose Radiotherapy for High-Risk Neuroblastoma After Intensive Chemotherapy and Surgery

Suchergebnisse filtern